Helus Pharma Inc. (HELP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Helus Pharma Inc. (HELP) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

HELP Cash Flow Statement

Helus Pharma Inc. (HELP) cash flow statement — 10-year operating, investing & financing cash flows

Metric	Q1'27	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22

Cash from Operations	-36.13M	-36.82M	-31.92M	-48.1M	-21.69M	-21.11M	-26.74M	-25.94M	-19.89M	-20.71M	-26.04M	-11.46M	-11.14M	-10.84M	-10.77M	-14.68M	-11.14M	-9.72M	-12.81M	-13.79M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-66.59%	-74.41%	-19.38%	-85.42%	-9.05%	-1.96%	-	-	-	-	-141.78%	21.94%	0%	-11.49%	15.94%	-6.46%	-25.44%	-47.98%	-50.93%	-53266.35%
Net Income	-46.6M	-46.34M	-42.63M	-47.03M	-18.07M	-30.58M	-10.84M	-56.9M	-10.83M	-21.35M	-30.33M	-11.89M	-13.05M	-13.72M	-10.74M	-9.97M	-13.05M	-18.1M	-17.21M	-17.61M
Depreciation & Amortization	30.21K	31K	21.98K	40.45K	27.23K	62K	135.18K	142.5K	101K	142K	142K	71K	53K	68K	71K	59K	53K	44K	44	42K
Stock-Based Compensation	0	0	4.47M	525.81K	552.69K	2.09M	3.44M	33.29M	2.9M	1.27M	9.93M	1.41M	1.27M	481K	978K	1.07M	2.15M	3.34M	4.46M	5.46M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	-10.45M	0	0	0	-1.17M	-2.18M	-537K	481K	0	0
Other Non-Cash Items	11.3M	5.8M	344.72K	8.22M	-1.43M	-1.25M	-19.68M	2.01M	-2.45M	-2.62M	13.05M	-1.98M	-222K	121K	-6K	15K	315K	1.44M	5.16M	6.66M
Working Capital Changes	-852.78K	3.69M	5.87M	-9.85M	-2.77M	8.56M	208.52K	-4.48M	-9.61M	1.84M	-8.38M	921K	-70K	2.21M	98K	-3.68M	-70K	3.07M	-875K	-2.2M
Change in Receivables	-9.75K	-258.71K	-30.97K	-878.68K	-8.07K	-302K	284.74K	-954.04K	-72K	-220K	-237K	-471K	-162K	-453K	242K	-575K	-162K	65K	114K	-606K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing	-311.87K	-318.44K	-382.69K	-608.1K	-162.21K	-1.08M	-312.06K	-340.63K	-173K	-215K	7.46M	-258K	-208K	-218K	-207K	-2.68M	-208K	-121K	-166K	-88K
Capital Expenditures	-311.87K	-318.42K	-382.69K	-608.1K	-169.55K	-1.08M	-312.06K	-340.63K	-173K	-8K	-172K	-258K	-208K	-218K	-207K	-2.68M	-208K	-121K	-166K	-88K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	-24	0	0	0	0	0	0	0	0	7.63M	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	7.34K	0	0	0	0	-207K	-159	-258	-65	-218	-207	-2.68K	-66	-108K	-144K	-67K
Cash from Financing	45.35M	-644.2K	143.63M	37.66K	40.1M	20.98M	-182.64K	-367.77K	-172K	190.86M	39.74M	20.38M	314K	5.14M	3.46M	4.65M	314K	67K	1.4M	33.98M
Debt Issued (Net)	0	-58.45K	-20.13M	0	32.66M	0	-116.48K	-89.57K	-63K	-93K	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	45.35M	-585.75K	163.69M	0	7.44M	20.49M	-517.71K	0	0	190.95M	1000K	1000K	1000K	1000K	1000K	1000K	0	0	0	1000K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	78.94K	37.66K	0	494K	451.56K	-278.21K	-109K	0	0	0	0	0	0	48K	314K	67K	1.4M	2.47M
Net Change in Cash	8.39M	-37M	111.29M	-48.73M	18.18M	-1.27M	-28.19M	-26.58M	-20.33M	169.99M	20.88M	8.77M	-11.18M	-5.88M	-7.43M	-12.52M	-11.18M	-9.94M	23.4M	-14.9M
Free Cash Flow	-36.44M	-37.14M	-32.3M	-48.71M	-21.86M	-22.2M	-27.05M	-26.28M	-20.06M	-20.92M	-26.21M	-11.72M	-11.35M	-11.06M	-10.98M	-17.36M	-11.35M	-9.84M	-12.98M	-13.88M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-66.72%	-67.32%	-19.42%	-85.33%	-8.95%	-6.09%	-	-	-	-	-138.79%	32.48%	0%	-12.33%	15.42%	-25.06%	-25.73%	-46.84%	-51.16%	-53606.86%
FCF per Share	-0.70	-0.74	-1.33	-2.01	-0.98	-1.06	-1.35	-1.31	-1.02	-1.05	-0.21	-0.05	-0.06	-0.06	-0.06	-0.10	-0.06	-0.06	-0.08	-0.08
FCF Conversion (FCF/Net Income)	0.78x	0.78x	0.75x	1.02x	0.88x	0.69x	2.47x	0.46x	1.84x	0.97x	0.86x	0.96x	0.90x	0.79x	1.00x	1.47x	0.85x	0.54x	0.74x	0.78x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0